IL6 as a mediator of insulin resistance: fat or fiction?

被引:33
作者
Allen, T. L. [1 ]
Febbraio, M. A. [1 ]
机构
[1] Baker IDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Melbourne, Vic 3008, Australia
关键词
IL6; Insulin sensitivity; Leptin; Obesity; NECROSIS-FACTOR-ALPHA; SUBCUTANEOUS ADIPOSE-TISSUE; ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; ACID OXIDATION; BODY-WEIGHT; IN-VITRO; INTERLEUKIN-6; OBESITY; SECRETION;
D O I
10.1007/s00125-009-1627-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:399 / 402
页数:4
相关论文
共 31 条
[1]   Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss [J].
Bastard, JP ;
Jardel, C ;
Bruckert, E ;
Blondy, P ;
Capeau, J ;
Laville, M ;
Vidal, H ;
Hainque, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (09) :3338-3342
[2]   Cytokine regulation of skeletal muscle fatty acid metabolism:: effect of interleukin-6 and tumor necrosis factor-α [J].
Bruce, CR ;
Dyck, DJ .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2004, 287 (04) :E616-E621
[3]   Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase [J].
Carey, Andrew L. ;
Steinberg, Gregory R. ;
Macaulay, S. Lance ;
Thomas, Walter G. ;
Holmes, Anna G. ;
Ramm, Georg ;
Prelovsek, Oja ;
Hohnen-Behrens, Cordula ;
Watt, Matthew J. ;
James, David E. ;
Kemp, Bruce E. ;
Pedersen, Bente K. ;
Febbraio, Mark A. .
DIABETES, 2006, 55 (10) :2688-2697
[4]   Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction [J].
Febbraio, MA ;
Hiscock, N ;
Sacchetti, M ;
Fischer, CP ;
Pedersen, BK .
DIABETES, 2004, 53 (07) :1643-1648
[5]   Gp130 receptor ligands as potential therapeutic targets for obesity [J].
Febbraio, Mark A. .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (04) :841-849
[6]   Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice [J].
Franckhauser, S. ;
Elias, I. ;
Sopasakis, V. Rotter ;
Ferre, T. ;
Nagaev, I. ;
Andersson, C. X. ;
Agudo, J. ;
Ruberte, J. ;
Bosch, F. ;
Smith, U. .
DIABETOLOGIA, 2008, 51 (07) :1306-1316
[7]   Skeletal myocytes are a source of interleukin-6 mRNA expression and protein release during contraction: evidence of fiber type specificity [J].
Hiscock, N ;
Chan, MHS ;
Bisucci, T ;
Darby, IA ;
Febbraio, MA .
FASEB JOURNAL, 2004, 18 (06) :992-+
[8]   Differential effects of interleukin-6 and-10 on skeletal muscle and liver insulin action in vivo [J].
Kim, HJ ;
Higashimori, T ;
Park, SY ;
Choi, H ;
Dong, JY ;
Kim, YJ ;
Noh, HL ;
Cho, YR ;
Cline, G ;
Kim, YB ;
Kim, JK .
DIABETES, 2004, 53 (04) :1060-1067
[9]   Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice [J].
Klover, PJ ;
Zimmers, TA ;
Koniaris, LG ;
Mooney, RA .
DIABETES, 2003, 52 (11) :2784-2789
[10]   Interleukin-6 depletion selectively improves hepatic insulin action in obesity [J].
Klover, PJ ;
Clementi, AH ;
Mooney, RA .
ENDOCRINOLOGY, 2005, 146 (08) :3417-3427